NTRP — NextTrip Share News
0.000.00%
- $21.04m
- $23.59m
- $3.72m
U.S. STOCKS ON THE MOVE-Caterpillar, Helen of Troy, chip stocks, Chinese stocks, Domino's Pizza
U.S. STOCKS ON THE MOVE-Domino's Pizza, Neurotrope, Aphria, U.S.-listed Chinese stocks
Neurotrope: Jumps on announcement of strategic review
Brief: Neurotrope To Evaluate Potential Opportunities For Lead Therapeutic Candidate Bryostatin
Cassava falls after posting data from Alzheimer's study
Brief: Neurotrope Inc Say Board Has Adopted A Shareholder Rights Plan
Brief: Neurotrope Announces Top-Line Results From Confirmatory Phase 2 Study Of Bryostatin-1 In Moderate To Severe Alzheimer's Disease
Neurotrope opens at record low after Alzheimer's drug fails trial
Neurotrope shares crash after Alzheimer's drug fails in trial
NASDAQ RESUMED
NASDAQ TRADE HALT HALT NEWS PENDING
Brief: George Haywood Reports 8.8% Passive Stake In Neurotrope Inc As Of August 26
Brief: Neurotrope Announces Publication On Potential Of Bryostatin In Neurorestorative Therapy
Brief: Neurotrope Announces Corporate Update And Reports Second Quarter 2019 Financial Results
Brief: Neurotrope Concludes Data Collection In Phase 2 Clinical Trial Of Moderately Severe To Severe Alzheimer's Disease
U.S. STOCKS ON THE MOVE-Tesla, GE, Nike, Southwest Airlines, Biogen
Forget Biogen, time to look at Neurotrope, INmune Bio - Maxim Group
Alzheimer's drug developers react as Biogen-Eisai bow out of trials
Alzheimer's drug developers react as Biogen-Eisai bow out of trials